ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, KITLG, SFRP2, NASP, MSH2, KIT]
GO:0090179;planar cell polarity pathway involved in neural tube closure;10.0;1.0;0.9152410118609203;9.628524252492122;275.5135961891709;7.212124270218933;0.009221192118313007;0.7840693824379941;[FZD1, SFRP2, CELSR1]
GO:0043508;negative regulation of JUN kinase activity;13.0;1.0;0.9625549647676366;9.628524252492122;4937.625749520049;7.138016298065211;0.16525789026176277;0.8275934502023958;[DUSP10, SFRP2, PTPN22]
GO:0090177;establishment of planar polarity involved in neural tube closure;6.0;1.0;0.8231203125901445;9.628524252492122;28.093926463720614;9.083926447120524;9.40278435848416E-4;0.7876727335416686;[CTHRC1]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, ACTN4, GREM1, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, CCL19, CD14, TNFSF14, TNFRSF10B, NLRP12, IL18R1]
GO:0021952;central nervous system projection neuron axonogenesis;10.0;0.7307253602413294;0.7806036919815851;8.935377071932177;67.09405391698027;6.686031174322154;0.002245577603873053;0.7571649570480019;[NR4A2, DCC, EPHB2, EPHB1]
GO:0046851;negative regulation of bone remodeling;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;58.83709634145716;7.138016298065211;0.0019692246645996656;0.6881587980249038;[GREM1, CALCA, IL6, INPP5D, TNFAIP3, CSK]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, PYCARD, TNFSF11, BTK, PRKCQ, S100A8, CARD11, TNFRSF11A, NLRP3, S100A12, TGFB1, NFKB1, MYD88, CD40, ITGB2, CD36, CHUK, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, BRCA1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, GHSR, ANXA1, ANXA3, GAB1, SIRT1, F3, GREM1, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0090291;negative regulation of osteoclast proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.65590509736859;9.083926447120524;0.0027998878581822827;0.8154717862087246;[GREM1, TNFAIP3]
GO:0008589;regulation of smoothened signaling pathway;6.0;0.7671156992804218;0.7066781622303554;9.0689084645567;41.8512380110395;5.500407508664414;0.0014007232725606145;0.6044114083783503;[IHH, CD3E, CTNNA1, PRKACB, PRRX1, RUNX2, POR, GAS1]
GO:0007413;axonal fasciculation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;31.514364772604104;6.7325511899570465;0.0010547574278521217;0.6952223462072524;[NRP1, CNR1, NCAM2, EPHB2, EPHA3]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, AVPR1A, SFRP2, MAP1B, S100A8, HBEGF, TAF9, PAK1, SFN, TGFB2, SYT2, FN1, CXCL12]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, TGFB1, MYB, F2R, IHH, ENG, CTGF]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, PHB2, SLC8A1, LOXL2, AQP1, PLAU, MYB, AKT1, PRKCE, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, NOX4, CD24, SUV39H1, ALAD, MYOCD, ADSL, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, PAK1, E2F1, TEK]
GO:0046580;negative regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;288.24654468039586;5.885253329569843;0.009647352445404638;0.6972127541467594;[STMN1, NUP62, TIMP2, EPHB2, TGFB2, ARAP3, BCL6, DLC1, FBP1]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, ASCL2, BTAF1, FLNA, NR1H2, CENPF, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, ZNF423, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD36, CBFA2T3, MDFIC, IL1B, DEPDC1, SATB2, PURA, CDX2, ARID4A, LOXL2, CHCHD3, BASP1, CCNE1, CALCA, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, MXD1, CREBZF, HMGB2, MYOCD, GREM1, IFNG, ELF3, FBP1, PFDN5, AURKB, SNCA, MEIS2]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, FOS, SIRT1, MMP12, CKS2, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, CXCL10, CIITA, HHEX, PPP1R12A, PEG3, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, TNFSF11, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, BRCA1, BRCA2, CD3D, RGMA, IL1B, YAP1, SATB2, IL17A, CD86, CD80, IHH, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, NUP62, YWHAH, MYOCD, CCNA2, GREM1, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, ENG, EPCAM, NR1H2, GTF2H1, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, KLF4, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, RHOG, MDFIC, TLR4, TLR2, CDX2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKAP2, DCN, DNM2, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, PDGFRA, TPM1, MSH2, TWIST1, GATA3, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, PTPRR, TMEM100, HHEX, TIE1]
GO:0030704;vitelline membrane formation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;111.92360708843823;9.777073627680469;0.0037459824045432497;0.8231203125901445;[IHH]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, TNR, DCC, SIRT1, GREM1, PSRC1, SFRP2, NDUFS3, FBP1, PAK1, FRZB, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, BCL6, SIPA1]
GO:0031915;positive regulation of synaptic plasticity;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;41.65758488823441;7.57984905034425;0.0013942418768168238;0.7626338329336335;[CDC20, PTGS2, EPHB2]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[IHH, DLL1, MEF2C, STIL, ENG]
GO:0061181;regulation of chondrocyte development;7.0;0.8259837884571596;0.7639112594857803;9.461470167828956;87.86935712531108;8.67846133901236;0.0029409083056968813;0.7947362817240173;[AXIN2]
GO:0001829;trophectodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;7.212124270218933;7.050676185779127E-4;0.6188283705770736;[CDX2, CNOT3, HOPX]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, ECM1, ITGB3, HMGB2, IHH, TNFAIP3, LAMC1, CDH3, AKT1, GHSR, ITGA4, ARG1, SIRT1, F3, PAX2, NME1, MMP12, AGTR1, C5AR1, TGFA, TWIST1, NOD2, IQGAP3, CCL5, HMOX1, PLCG1, JUN, TGFB1, EGR3, CAV2, TNFSF12, LAMB1, NR4A1, BMP2, LRG1, CXCL12, NR4A3, ID1, TEK]
GO:0070602;regulation of centromeric sister chromatid cohesion;9.0;0.811012628672052;0.801746939516315;9.34084218004034;56.72753252279278;8.390779266560578;0.0018986194620731454;0.8253454670833372;[AXIN2]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, SFRP2, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, IL6]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, HMOX1, DAPK1, TNFRSF10B, SFRP2]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[GREM1, SFRP4, SYK, EGF, FMR1, NTF3, SELE]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, IHH, SPINT2, ANTXR1, CLU, CDH5, C1GALT1C1, CDH3, CDH1, MEF2C, ACTN1, COL23A1, CLDN3, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ECT2, ST14, TGFB2, BCL11B, VDR, FN1, BCL6, ID1, NOX4, NRP1, COL14A1, ITGB3, LAMC1, ITGB7, ITGA4, GP1BA, GREM1, PALLD, COL6A3, YAP1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:0045930;negative regulation of mitotic cell cycle;6.0;0.5833093054345528;0.6147749653074209;7.836764783264067;61.236897459641845;4.271742091748107;0.0020495438483445192;0.5415774018184651;[ZWILCH, BUB1B, TNF, CHEK1, KNTC1, SOX4, MSH6, MSH2, AURKAIP1, BLM, CCNB1, NACC2, SFN, NAE1, TGFB1, PLK2, PLK1, CDC6, ZWINT, BCL6, CNOT3, CDK1, EZH2, TOP2A, CDKN1A, BRCA1, TIMP2, TOPBP1, DUSP1, TFDP1, GAS1, PCNA, AURKB, GPNMB, E2F1, CCL2, BUB1, E2F7, DONSON, KLF4, WEE1, CENPF, FAP, MAD2L1]
GO:0042662;negative regulation of mesodermal cell fate specification;10.0;0.8436909121759173;0.837086467948879;9.503361109538115;745.9340364622068;8.390779266560578;0.02496574090334154;0.8443458537639685;[SFRP2]
GO:0060997;dendritic spine morphogenesis;8.0;1.0;0.875;9.628524252492122;122.19110678714402;6.8867018697843045;0.004089626379309125;0.7271862538851576;[EPHB2, EPHB1, SHANK3]
GO:0090190;positive regulation of branching involved in ureteric bud morphogenesis;8.0;1.0;0.875;9.628524252492122;298.04283299406984;6.832634648514029;0.009975225399176214;0.7244212536750128;[GREM1, TGFB1, HOXB7, LGR4, PAX2]
GO:0003337;mesenchymal to epithelial transition involved in metanephros morphogenesis;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;100.75338661320167;7.697632086000634;0.0033721251777828433;0.7167775754447168;[GREM1, PAX2]
GO:0051893;regulation of focal adhesion assembly;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;59.47724087459839;5.769740442447999;0.0019906497260312257;0.6459841598043611;[NRP1, ARHGAP6, THBS1, EPB41L5, PTK2, GREM1, DLC1, TEK, EPHA3]
GO:0071481;cellular response to X-ray;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;7.379178354882098;0.0020214916980741903;0.728290889492758;[SFRP2, DNM2]
GO:0048255;mRNA stabilization;10.0;0.8933024483968273;0.861892236059334;9.577230958104572;1968.7172834448895;6.088194173566533;0.06589119574637584;0.7265915450270957;[SLC11A1, AXIN2, MAPK14, E2F1, MYD88]
GO:0050680;negative regulation of epithelial cell proliferation;6.0;0.7307253602413294;0.6884829927108091;8.690254613899192;65.19530579150691;4.989581884898423;0.0021820282128758306;0.5782877622231366;[SPARC, PRL, PTPRK, BRCA2, PHB2, TNF, DUSP10, MEN1, MEF2C, EREG, TGFBR3, CEACAM1, SFRP2, GATA3, THBS1, CCL2, SFN, TGFB2, TGFB1, CAV2, VDR, CAV1, NR2F2, SNAI2]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB2, EPHB1, AP2M1, MMP2, MMP9, EPHA3, EPHA2, SDC2, PAK1, FYN, LYN, PTK2]
GO:0099557;trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission;8.0;1.0;0.875;9.628524252492122;77.47691422773288;9.777073627680469;0.002593082594506325;0.875;[EPHB2]
GO:0010942;positive regulation of cell death;5.0;0.5391707831400974;0.559826403430969;7.325939159498076;41.77857356132841;3.304727333179569;0.0013982912588225433;0.45924492136526085;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CDKN1A, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, FOS, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, HP, TNF, CLU, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, ITGAM, PLEKHF1, LRRK2, ITGB2, FASLG, CYR61, ITGA4, TFDP1, LCK, LRP1, NLRC4, CCL5, E2F1, CCL2, FYN, P2RX1, MNDA, FCGR2B, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, IFI27, SIK1, INPP5D, TP53BP2, EGR1, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, CD36, VAV1, IL1B, TLR6, TLR4, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, KMO, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, AXIN2, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, LTBR]
GO:0010667;negative regulation of cardiac muscle cell apoptotic process;10.0;1.0;0.9152410118609203;9.628524252492122;149.61163774803944;6.781341354126479;0.005007366873694588;0.7620391240755716;[MYOCD, SFRP2]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[, NUP107, F11R, AKT1, SEH1L, NUP85, EPB41L3, NUP88, JUP, PLK1, COL1A1, EHD3, EZH2, LRRC4, MMP12, CENPA, FLNA, DMD, CSE1L, TNF, CLU, CDH1, RUVBL2, LAMP2, CD177, RAB32, PKP3, SLC27A2, LIN7A, NACC2, REEP1, CDK1, PLEKHF1, LRRK2, ITGB2, ITGAL, HHEX, ITGB7, ITGA4, PPP1R15A, NLGN1, TSPAN33, TSPAN15, DNAJA3, VPS41, PAQR3, GOLPH3L, ESCO2, TSPAN5, ID1, CD24, NRP1, PTPRK, BRCA2, TRAM2, XPO1, FCER1G, SYK, RAB33B, MIS12, HSD17B4, CTNNA1, RANBP2, RANBP1, RPA1, RANBP6, RAMP1, SCARB2, BUB1B, CELSR1, TTC7B, TSC2, ATP1B1, HGS, VCL, STIL, NUP155, CAV1, TNFAIP3, NUP62, NUP133, AXIN2, EHHADH, NUP54, SHANK3, AURKB, HSPD1, NUP35, RAN]
GO:0035264;multicellular organism growth;3.0;1.0;0.6981203125901445;9.628524252492122;22.582921643529833;5.382624473008031;7.558300640989654E-4;0.47338797845741154;[IHH, BRCA2, HHEX, SLITRK6, HOXA5, STIL, RMI1, GRHL2, NDUFS6]
GO:0046639;negative regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1319.9697280350817;6.599019797332524;0.04417819890170367;0.7527151911823093;[ANXA1, IHH, BCL6]
GO:0033089;positive regulation of T cell differentiation in thymus;10.0;0.8933024483968273;0.861892236059334;9.577230958104572;998.0942985465404;7.292166977892469;0.03340531794580182;0.7881627702307852;[EGR3, VNN1, IL1B, IHH]
GO:0033088;negative regulation of immature T cell proliferation in thymus;11.0;1.0;0.9324289523296623;9.628524252492122;1903.3648394554518;8.390779266560578;0.06370390825943047;0.8615337942327104;[IHH]
GO:1900273;positive regulation of long-term synaptic potentiation;9.0;1.0;0.896240625180289;9.628524252492122;146.46287151967024;6.832634648514029;0.004901980501736697;0.7456618788553018;[EPHB2, SHANK3, NRGN]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPARC, SPINT2, PHB2, CYP1B1, EPHB1, SOX7, SOX4, MEF2C, EREG, SFRP4, SFRP2, SPINT1, BTK, GATA3, INPP5D, HMOX1, SFN, LYN, JUN, BCL11B, FZD5, LIF, CDC6, NR2F2, NOX4, SNAI2, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, LRRC32, TIMP2, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, CEACAM1, IL1B, TLR2, PTGS2, ASCL2, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, LILRB1, LILRB2, PODN, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, CDH5, DACH1, MEN1, IGFBP5, F2R, TPM1, TSC2, ADCYAP1, HGS, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, LTA, XCL1, PDE5A, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:1900155;negative regulation of bone trabecula formation;7.0;1.0;0.8509193652572005;9.628524252492122;103.37187714017627;9.083926447120524;0.003459763699232205;0.8154717862087246;[GREM1]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, CDKN1A, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, CDK1, HPSE, ITGB3, FASLG, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PURA, PAK1, CXCR2, CDX2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, IL6R, PDGFRB, GHSR, PDGFRA, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0045665;negative regulation of neuron differentiation;8.0;0.6162540371078848;0.6831270185539424;8.732436227935485;338.1488864638422;4.401795219996305;0.011317538915704735;0.6001080122550225;[SEMA5B, EDNRB, LGALS1, ARHGDIA, TNR, HOXA2, EPHB2, PAQR3, JAG1, PLK2, PTK2, ID1, ITM2C, NRP1, LRRK2, CTSZ, ARHGAP4, YWHAH, DCC, RGMA, IL1B, NLGN1, LRP1, DLL1, LINGO1, SEMA4B, IRX3, MEIS1, PMP22]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, ADCYAP1, MAP1B, EPHA3, SOCS2, ECT2, LYN, FZD1, SYT2, FN1, BMP2, CXCL12, LIN28A, BCL6, FES, PLXNB2, TCF4, EZH2, ROBO2, NRP1, TIMP2, NME1, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, IRX3, FKBP1B]
GO:0002063;chondrocyte development;4.0;0.8933024483968273;0.6966512241984136;9.474373572664863;32.15320660831846;6.943860283624253;0.001076138889173156;0.6051093378270707;[SFRP2, COL11A1, RUNX2, SULF2]
GO:1900158;negative regulation of bone mineralization involved in bone maturation;8.0;1.0;0.875;9.628524252492122;331.8336746313108;8.390779266560578;0.011106174458991567;0.8041048419030481;[GREM1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, PRL, BRCA1, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, SATB2, LILRB1, GRHL2, IL17A, IHH, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, GREM1, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, MAPK14, ASCL2, PTK2, DCN, E2F7]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CYR61, IL6R, CTHRC1, MEF2C, JAG1, RUNX2, IL6, BMP2, SFRP2, LTF]
GO:0006029;proteoglycan metabolic process;6.0;0.7140352122741334;0.6801379187272112;9.057979394024509;96.66964063832829;5.825829909099042;0.0032354458751365986;0.6210535250702663;[COL11A1, IHH, ADAMTS12, NDST3, HS3ST3B1, SULF2, BMP2, HPSE]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[CD86, CD83, CD80, IHH, MYB, NLRP3, NCKAP1L, CCL19, IL12RB1, ANXA1, SYK, ZAP70, IFNG]
GO:0045668;negative regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;170.3268387162597;6.015873511986907;0.0057006860076304205;0.6307723637598831;[IGFBP5, TWIST1, TMEM64, AXIN2, TNF, GREM1, ID1, HOXA2, MEN1]
GO:0051389;inactivation of MAPKK activity;12.0;1.0;0.9481203125901445;9.628524252492122;2444.6724912788027;9.083926447120524;0.08182098822069953;0.9126727335416687;[EPHB2]
GO:0072086;specification of loop of Henle identity;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;26.263961959279975;8.390779266560578;8.790311707459184E-4;0.7193458537639684;[IRX3]
GO:0071310;cellular response to organic substance;4.0;0.44223782556504454;0.47111891278252227;5.954033535830285;41.65973036582596;2.624021992742989;0.0013943136840210083;0.3841926067383783;[CYFIP1, PID1, SPI1, TFRC, SERPINE1, SPINT2, PHB2, MYB, AKT1, HOXA2, CYP1B1, PRKACB, MEF2C, DAPK1, PRKCE, PRKCD, ADCY9, SPINT1, PRKAR1B, PADI2, ABCB4, FPR2, GATA3, SLC30A10, ADAMTS12, IQGAP3, EPB41L5, KLRK1, PRKAR2B, PDGFD, PDGFC, ST3GAL6, PLCG1, LYN, ABCA1, JUN, JUP, CDC6, COL1A1, COL1A2, NOX4, SNAI2, EZH2, GABRB1, TIMP3, HLA-DPA1, HAVCR2, ANXA1, DUSP1, ARG1, FOS, SIRT1, PAX2, GAS1, CCL13, PTAFR, PTGS2, CCL19, CCL18, IL12RB1, P2RY13, CCL23, GSN, CCL21, CCL20, NR1H2, ZYX, PF4, TNC, CXCL13, TNF, SLC8A1, PYCARD, CDH1, RUVBL2, MEN1, TLE4, LHCGR, DGAT2, IGFBP5, CD180, ADCYAP1, ADAM9, CD274, CSF1R, BLM, CALCRL, CORO1A, FOXO1, SOCS2, PSAP, IGFBP7, MAP2K6, OSBPL7, DEFA4, DEFA1, NFKB1, CXCL10, CXCL11, SLC26A3, MCM7, LRRK2, TREM2, PTPN22, ALAD, CHUK, ITGA4, TNFRSF1B, IL3RA, XCL1, MCM2, CX3CR1, LRP1, CEBPE, NOD2, P2RY6, CCL8, CCL7, CCL5, CCL4, E2F1, CCL2, CCL1, FYN, CSK, KLF4, KLF1, RAD51, KLF5, IMPDH2, PTPN6, FCGR2B, IL1RN, SPARC, AQP9, AQP1, TCL1A, EDNRB, LGALS1, TNFSF11, SOX4, PTGDR, RUNX2, POR, KCNQ1, BTK, SIK1, EPHA3, CFTR, STXBP2, TWIST1, CD14, EGR1, EGR2, EGR3, PPBP, ID1, ROBO2, NRP1, CD40, BRCA1, CTSS, CTSH, FFAR2, CTSG, CCR7, CD36, CCR5, CTSB, MAP4K1, MME, PDCD1LG2, AVPR1A, NME1, CEACAM1, IL1B, KIT, TLR6, TLR4, TLR2, YAP1, DTYMK, PTGER2, SATB2, CXCR4, GNAI1, PAK1, CTNNA1, CD58, LILRB1, LILRB2, SORBS1, NLRP12, CD68, RAMP1, IL18R1, IL17A, CD86, CD80, PDGFRB, GHSR, PDGFRA, PCOLCE, KMO, KIF16B, COL4A1, CALCA, CSF2RB, ADRB2, CCNB1, STAP1, NLRP3, GAS2L1, TGFB1, VCAM1, CAV1, INHBA, BSPRY, NR4A2, NFKBIA, NR4A1, IL6, BMP2, KIF18A, LIN28A, NR4A3, ALPL, CXCL6, CXCL9, HMGB2, TNFAIP3, CXCL1, CXCL3, CXCL2, CXCL5, GHR, TMEM100, GRM5, PDE4B, MMP2, GLP2R, CAD, DNM2, CCNA2, CHI3L1, COLEC12, THBS1, SNCA, MAPK14, TSHR, CD4, RBMX]
GO:0060708;spongiotrophoblast differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;8.390779266560578;0.0014155633914202197;0.7193458537639684;[LIF, ASCL2]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, IHH, CYR61, FBL, AKT1, MEF2C, TPM4, IGFBP5, RUNX2, EPHA2, HSD17B4, TWIST1, GPNMB, FIGNL1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, SNAI2, RBMX, LGR4]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[TGFB2, SFRP2, SYK, CCL21, CCL5, ADAM9, NCKAP1L, PTPN6, CXCL13]
GO:0032423;regulation of mismatch repair;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;106.94291367646407;8.67846133901236;0.0035792830783775275;0.8188169164668168;[AXIN2]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[PPP2R1A, NTF3, CAV1, PRKCD, SFRP2, PTPN6]
GO:2000273;positive regulation of signaling receptor activity;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;204.98744489530804;6.311337724880743;0.006860745303922797;0.6736814700148209;[EGF, PRKCE, TGFA, ADRB2, EREG, GREM1, EPHB2, SHANK3]
GO:0061185;negative regulation of dermatome development;7.0;1.0;0.8509193652572005;9.628524252492122;121.41107568444949;9.777073627680469;0.004063519440284355;0.8509193652572005;[SFRP2]
GO:0008333;endosome to lysosome transport;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;62.67584315854233;5.769740442447999;0.0020977040659196657;0.618185107137305;[ADRB2, CDX2, SORT1, VPS41]
GO:0002076;osteoblast development;4.0;1.0;0.75;9.628524252492122;32.15320660831846;6.832634648514029;0.001076138889173156;0.5994212536750128;[SATB2, CLEC5A, HOXA2, RUNX2, MEN1]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[ROBO2, GABRB1, FMR1, IHH, MEF2C, NPY, TGFB2, GABRA5, LIF, SLC4A7, UQCRQ]
GO:0048704;embryonic skeletal system morphogenesis;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;45.48774390093071;5.346256828837156;0.0015224338520524504;0.5636488347140203;[COL11A1, SATB2, TWIST1, HOXA11, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, PDGFRA, PRRX1, PAX5, GRHL2, RUNX2, HOXB4, HOXB3, HOXB2, HOXB7, DSCAML1, HOXB6, HOXB5]
GO:0030514;negative regulation of BMP signaling pathway;12.0;0.8259837884571596;0.8611122068187244;9.4949928598676;599.3292772798114;5.905872616772578;0.02005901154922404;0.7501469128630576;[FZD1, LRP2, GREM1, SFRP2]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[PAX2, HOXA11, GREM1, BMP2]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, CDC6, AZU1, NOX4, EZH2, CDKN1A, TIMP2, HAVCR2, GPR37, FCRL3, SIRT1, DUSP6, CKS2, HBEGF, ENG, CCL13, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CCNT2, FMR1, TNF, CLU, CTGF, PYCARD, IFNA14, MAP2K2, IFNA16, F2R, ADCYAP1, ADAM9, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, CYR61, XCL1, LCP2, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, TCL1A, EDNRB, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, EPHA3, EPHA2, TGFA, CCR1, EGR1, LIF, PTK2, MARCO, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, SYK, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, GNAI2, PAK1, CD40LG, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, CCNB1, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GHR, GRM5, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[TGFB2, COL14A1, LUM, COL11A1, COL12A1, LOXL2, COL1A1, GREM1, SFRP2, COL1A2, COL5A1, CYP1B1]
GO:0035924;cellular response to vascular endothelial growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;62.59148538135601;6.599019797332524;0.00209488068703431;0.6605944919115335;[NR4A1, NRP1, EGR3, ANXA1, VCAM1, AKT1, GAS1, MAPK14]
GO:0007171;activation of transmembrane receptor protein tyrosine kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1143.6879814690685;7.212124270218933;0.03827820748741112;0.8169486831672182;[GREM1, EGF, PDGFC, ADRB2]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, MSH2, IFNG, GAS1, PPP1R15A, CUL5, THBS1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, DHCR24, INHBA, FAP, JMY]
GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;831.2496569477559;6.409777797693995;0.02782117794191935;0.7430373465201421;[TAF9, MIF, SIRT1, CLU, CXCL12, SFRP2, SNAI2]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA2, FGF5, EFEMP1, GRAP2, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, CSF2RB, MAP2K6, LYN, LIF, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, SYK, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[NRP1, PLXND1, LRRK2, MEN1, MEF2C, MMP9, LRP1, EPB41L5, CTHRC1, PLK2, CAV1, BMP2, RAN]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[CSF1R, TGFA, GRM5, CCL5, STAP1, FYN, ACE, EGF, EREG, GREM1, CD24]
GO:2000041;negative regulation of planar cell polarity pathway involved in axis elongation;10.0;1.0;0.9152410118609203;9.628524252492122;455.7071039869726;9.083926447120524;0.015252106660676964;0.8797934328124444;[SFRP2]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, HOXA5, SOX4, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, SATB2, FLNA, CDX2, GTF2H1, GRHL2, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, MAFF, MYOCD, TFDP1, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF5, POU2AF1, TAF5, RBMX]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[PTGS2, FRZB, PRDM16, AKT1, TMEM64, MAPK14, BMP2, KLF5, SFRP2]
GO:0048557;embryonic digestive tract morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;31.256231937100466;6.832634648514029;0.0010461179541522844;0.639662265535933;[PDGFRA, IHH]
GO:0002042;cell migration involved in sprouting angiogenesis;9.0;1.0;0.896240625180289;9.628524252492122;27.169092758590633;7.069023426578259;9.093250840340128E-4;0.757750811958709;[GREM1, NR4A1, NRP1, EGR3]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, TIAM2, DEPDC1B, LLGL2, EPHA2, RACGAP1, NCKAP1L, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, ARHGAP15, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, ARHGAP11A, DOCK4, LRRK2, TAGAP, ARHGEF12, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0003257;positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;1976.410959106372;8.390779266560578;0.06614869614690709;0.8916598066706847;[GREM1, MYOCD]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, AQP1, RPS6KA1, AKT1, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, SOX4, WLS, TLE4, SFRP4, HOXB9, SFRP2, CCNE1, DAAM2, PFN1, GATA3, APCDD1, FZD1, FZD5, FZD8, NR4A2, VANGL1, SDC1, SNAI2, CD24, CDK14, LRRK2, TGFB1I1, HHEX, AXIN2, AES, FRZB, CTHRC1, EGF, TMEM64, KLF4, LGR4]
GO:0010975;regulation of neuron projection development;8.0;0.5673924682959377;0.6586962341479689;8.404748820870006;84.29486529122617;3.652390236786265;0.0028212732808438556;0.5617834065627654;[CYFIP1, CPNE5, CDC20, LGALS1, DPYSL2, AKT1, EPHB2, MEF2C, PAQR3, SFRP2, MAP1B, EPHA3, SDC2, GATA3, LYN, FZD1, PLK2, FN1, PTK2, ID1, EZH2, ITM2C, ROBO2, NRP1, CTSZ, ARHGAP4, RGMA, NME1, PAK1, FKBP1B, SCARB2, SEMA5B, PLXND1, FMR1, ARHGDIA, TNR, ADCYAP1, SYT2, CXCL12, FES, PLXNB2, LRRK2, YWHAH, DCC, DNM2, SHANK3, NLGN1, LRP1, RAB21, CNR1, FYN, LINGO1, PRRX1, SEMA4B, KLF4, PMP22]
GO:0051965;positive regulation of synapse assembly;7.0;0.8259837884571596;0.7639112594857803;9.437469015729413;224.643362448917;5.602686357784832;0.007518611175264769;0.6374410061458773;[NLGN1, AMIGO3, LRRN3, THBS2, FLRT2, SLITRK6, EPHB2, EPHB1]
GO:0050910;detection of mechanical stimulus involved in sensory perception of sound;6.0;1.0;0.8231203125901445;9.628524252492122;83.9288867027761;7.379178354882098;0.0028090243068477775;0.7004918368257019;[COL11A1, KIT]
GO:1904782;negative regulation of NMDA glutamate receptor activity;10.0;1.0;0.9152410118609203;9.628524252492122;1128.6707270406114;9.777073627680469;0.0377755934963422;0.9152410118609203;[EPHB2]
GO:0033690;positive regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.379178354882098;0.0021103132289136558;0.7004918368257019;[BMP2, HPSE, CYR61, LTF, CTHRC1]
GO:0090027;negative regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;861.9877169990635;8.390779266560578;0.02884995314937857;0.8443458537639685;[GREM1]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, APLP2, F2R, NPY1R, DGKZ, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, ARHGEF12, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0021902;commitment of neuronal cell to specific neuron type in forebrain;6.0;1.0;0.8231203125901445;9.628524252492122;23.23527948316835;7.8311634786251565;7.776638939077275E-4;0.7236063770733796;[BCL11B, SATB2]
GO:0060394;negative regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1014.8354762495777;7.379178354882098;0.03396563009744072;0.7926125360964777;[GREM1, EMILIN1]
GO:1904783;positive regulation of NMDA glutamate receptor activity;10.0;1.0;0.9152410118609203;9.628524252492122;1126.3301560195273;9.083926447120524;0.03769725669064368;0.8797934328124444;[EPHB2]
GO:0003382;epithelial cell morphogenesis;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;47.452274261266446;6.409777797693995;0.0015881849152503491;0.6509166472493662;[ST14, BCL11B, COL23A1, IHH, SPINT2, GRHL2, CLDN3, PALLD, ID1]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, WLS, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, SFRP2, DAAM2, LGR4, NAIP]
GO:0060712;spongiotrophoblast layer development;4.0;1.0;0.75;9.628524252492122;49.67194865438347;7.697632086000634;0.0016624754196107158;0.6436572628545723;[ASCL2]
GO:0007224;smoothened signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;5.528578385631111;8.87013979980389E-4;0.6058520683365068;[IHH, STIL]
GO:0002053;positive regulation of mesenchymal cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;64.15119587261817;6.444869117505266;0.002147082793528545;0.6527112189764278;[PRRX1, IHH, PDGFA]
GO:0060711;labyrinthine layer development;4.0;1.0;0.75;9.628524252492122;34.608406302298;7.697632086000634;0.001158312213394382;0.6436572628545723;[CDX2]
GO:2000727;positive regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;667.9527156383532;6.8867018697843045;0.02235577627399952;0.7484268790654467;[GREM1, MEF2C, MYOCD, TGFB1]
GO:0003413;chondrocyte differentiation involved in endochondral bone morphogenesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.066225782797595;8.16763571524637;7.050676185779127E-4;0.7079342821725234;[IHH, AXIN2]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[AURKB, CCT4, CCT2, KLF4, GRHL2, GREM1, PRKCQ]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, LAMP2, SKP2, SFRP2, SIK1, ATF3, SEH1L, ABCB4, FOXO1, HMOX1, GAS2L1, LYN, JUN, EIF2S1, NR4A2, COL1A1, CDKN1A, PLEKHF1, LRRK2, ASGR1, UPP1, AVPR1A, FOS, SIRT1, AES, PTGS2, FYN, SIPA1]
GO:0010626;negative regulation of Schwann cell proliferation;10.0;0.9326813400603323;0.8815816818910864;9.590783924509275;548.146883897569;7.9853141584524145;0.018345982903883885;0.8236103492792612;[ASCL2]
GO:0001756;somitogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;43.80328827915336;5.845247994956144;0.0014660566383032007;0.5891672661548076;[AXIN2, DLL1]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, CKS2, PTAFR, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, CXCL10, MYD88, CIITA, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, TNFSF11, EPHB2, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, BRCA1, BRCA2, CD3E, CD3D, CTSH, CD36, CD34, RGMA, IL1B, KIT, YAP1, SATB2, IL17A, CD86, CD80, IHH, ACTG2, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, NUP62, YWHAH, MYOCD, ACTA2, CCNA2, GREM1, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ENG, EPCAM, GSN, NR1H2, GTF2H1, PLP1, PF4, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, MEN1, MAP2K2, F2R, ADAM2, COPS5, MAFF, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, RHOG, MDFIC, TLR6, TLR4, TLR2, CDX2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, SLC40A1, CKAP2, AXIN2, DCN, DNM2, IFNG, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[LAMB3, ITGB5, ITGA4, COL11A1, MMP2, LAMA3, COL12A1, ITGB2, FN1, LAMB1, INHBA, MMP8, MMP9, COL8A1, ITGA7]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, CTGF, RUVBL2, PDGFRB, GHSR, ANXA1, DUSP1, TACR3, CCNA2, IL1B, PCNA, ABCB4, PTGS2, SOCS2, RBBP8, TGFB1, NR2F2, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, EPHB2, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, GREM1, IFNG, IL1B, LTA, XCL1, SHANK3, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0033689;negative regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.18040277096193;7.57984905034425;0.0021145912220731796;0.710754145523778;[GREM1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, SERPINE1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, ENG, CX3CR1, LRP1, THBS1, CCL2, CCL21, TIE1, PODN, KLF4, DLC1]
GO:0048170;positive regulation of long-term neuronal synaptic plasticity;10.0;1.0;0.9152410118609203;9.628524252492122;315.9495864907144;8.16763571524637;0.010574548323677036;0.8329342821725234;[KIT, EPHB2, SHANK3]
GO:0060220;camera-type eye photoreceptor cell fate commitment;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;23.92842666372706;9.777073627680469;8.00862906249065E-4;0.8509193652572005;[IHH]
GO:1903225;negative regulation of endodermal cell differentiation;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;302.8138100707639;8.67846133901236;0.010134905708332559;0.8188169164668168;[COL5A1]
GO:1904837;beta-catenin-TCF complex assembly;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;6.409777797693995;0.0013529121422039536;0.618037346520142;[TLE4, AXIN2, RUVBL1, MEN1]
GO:0090191;negative regulation of branching involved in ureteric bud morphogenesis;8.0;0.8933024483968273;0.8216512241984136;9.577230958104572;298.2680508904603;8.390779266560578;0.009982763239485454;0.8041048419030481;[GREM1, TACSTD2]
GO:1904956;regulation of midbrain dopaminergic neuron differentiation;9.0;0.8259837884571596;0.8092325194088689;9.485423408851448;65.91985791570636;8.16763571524637;0.002206278320418209;0.8139338954918922;[SFRP2]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, ASCL2, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, PEG3, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, IL1B, SATB2, CDX2, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, FBP1, AURKB, SNCA, MEIS2]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[TGFB1I1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, BMP2, IL1B, EZH2, ENG]
GO:0010717;regulation of epithelial to mesenchymal transition;5.0;0.7140352122741334;0.6472586179979869;8.999915593069748;54.42428208907013;5.395046993006588;0.001821531742847262;0.5661439659786197;[TGFB1I1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, GREM1, BMP2, SFRP2, IL1B, EPHA3, EZH2, ENG]
GO:0030326;embryonic limb morphogenesis;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;43.30626768056369;5.395046993006588;0.0014494218061579028;0.5661439659786197;[TWIST1, AFF3, HOXC10, HOXA11, HOXA10, TGFB2, PRRX1, RUNX2, GREM1]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[PCNA, TGFB1, IHH, SULF2, NFKBIA, HMOX1, EZH2]
GO:0050771;negative regulation of axonogenesis;10.0;0.7436939687323844;0.7870879962271125;9.36383169826504;885.0968544383536;5.54296712308321;0.029623395182598163;0.6987086083097278;[NRP1, SEMA5B, ARHGAP4, ARHGDIA, TNR, EPHB2, LINGO1, DCC, SEMA4B, PTK2]
GO:0010719;negative regulation of epithelial to mesenchymal transition;6.0;0.8259837884571596;0.7361122068187242;9.434368238051164;171.1659509920613;6.481236761676141;0.005728770340349481;0.6545710619905948;[TGFB2, SFRP2]
GO:0043570;maintenance of DNA repeat elements;7.0;0.811012628672052;0.7564256795932265;9.446202695698167;170.28329447847625;8.16763571524637;0.005699228621179078;0.7686126355688037;[MSH6, MSH2, AXIN2]
GO:0060628;regulation of ER to Golgi vesicle-mediated transport;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;59.76207228951576;7.004484905440688;0.0020001827771568793;0.6813299963962409;[GAS1]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[NRP1, PLXND1, IHH, SFRP2, COL4A1, ENG]
GO:0045112;integrin biosynthetic process;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;39.16312370347755;9.777073627680469;0.0013107545058323288;0.7902410118609202;[COL5A1]
GO:0010955;negative regulation of protein processing;9.0;0.7192862368539868;0.7558837436072825;9.27570287786938;707.1969765737138;6.039404009397101;0.023669246369964203;0.705096027081865;[LRRK2, CTSZ, SERPINE1, NLRC4, THBS1, CR1, IL1R2, GAS1, BIRC5, NAIP]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[LRRK2, GATA3, CDH3, FRZB, SOX4, FZD1, FZD5, EGF, FZD8, TMEM64, KLF4, NR4A2, SFRP4, HOXB9, SFRP2, SDC1, SNAI2, LGR4]
GO:0033674;positive regulation of kinase activity;9.0;0.6073376606709605;0.6999094555157693;8.620883742029738;265.89784403492143;3.4106031799490317;0.008899361547325376;0.5706590304121504;[, IL1RN, CCNH, TCL1A, AKT1, PROK2, TNFSF11, EPHB2, EPHB1, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, EPHA3, EPHA2, FPR1, TGFA, PDGFA, FPR2, IQGAP3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, EGR1, ACE, FZD5, FZD8, CDC6, AZU1, PTK2, NOX4, CD24, EZH2, CDKN1A, CD40, CCR7, MAP4K1, SYK, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CCL21, CENPE, CD40LG, PKN1, CCNT2, TNF, CLU, IL6R, PDGFRB, PDGFRA, MAP2K2, F2R, ADCYAP1, ADAM9, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, CCNB1, STAP1, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, CYR61, GHR, GRM5, FGR, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, TIE1, MAPK14, CD4, RAD50, TEK]
GO:0060071;Wnt signaling pathway, planar cell polarity pathway;9.0;0.7436939687323844;0.7680876095464813;9.094441766561864;99.0414819593438;5.825829909099042;0.0033148292696323837;0.694173837660411;[CELSR1, AP2M1, CTHRC1, FZD1, FZD5, VANGL1, SFRP2, PFN1]
GO:0010950;positive regulation of endopeptidase activity;10.0;0.7436939687323844;0.7870879962271125;9.418803721510052;499.32903666023907;4.7018998124466425;0.01671209349006058;0.6556963869301439;[TNF, CTGF, PYCARD, SOX7, DAPK1, F2R, SFRP2, IFI27, S100A8, PSMD14, NLRP3, LYN, TNFRSF10B, FASLG, CYR61, CTSH, CR1, SIRT1, F3, LCK, NLRC4, HSPD1, PERP, FYN, SNCA, CASP8AP2, GSN, HSPE1, NLRP12, P2RX1, DLC1]
GO:0060575;intestinal epithelial cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;7.8311634786251565;8.564078129062366E-4;0.7236063770733796;[CDX2]
GO:0016539;intein-mediated protein splicing;8.0;1.0;0.875;9.628524252492122;103.27637126680544;9.083926447120524;0.003456567203600189;0.839552420951524;[IHH]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, JUN, HACE1, NR2F2, EZH2, HOXC10, CHAF1B, FOS, SIRT1, STAT4, FLNA, ZNF467, CASP8AP2, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, CIITA, FASLG, HHEX, BIRC5, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, UXT, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, LOXL2, HMGA1, MXD1, HMGB2, AFF3, NUP62, MYOCD, ELF3, CREB5, TAF9, MAPK14, TAF5, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, SNAI2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, ASCL2, GTF2H1, MEN1, TLE4, NACC2, MAP2K6, HOPX, COPS5, BCL6, CNOT3, MAFF, LBH, RFC1, TFDP1, SMARCD3, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, KLF1, KLF8, KLF5, MNDA, ZNF608, DPF3, SOX7, SOX4, EBF1, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, PURA, CDX2, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, C5AR1, NLRP3, CBX4, NR4A2, CREBZF, KDM5D, LTF, MEIS2, MEIS1, RBMX]
GO:1900086;positive regulation of peptidyl-tyrosine autophosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1786.9389585583017;8.16763571524637;0.05980723880229299;0.8501222226412654;[GREM1, ACE, SYK]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[LRP1, TREM2, AKT1, EPHB2, PRKCE, RHOG, SORBS1, IFNG, EPHA3, EPHA2]
GO:0090244;Wnt signaling pathway involved in somitogenesis;8.0;1.0;0.875;9.628524252492122;31.415129658942366;8.390779266560578;0.0010514361179036673;0.8041048419030481;[SFRP2]
GO:0045597;positive regulation of cell differentiation;5.0;0.4493394816318884;0.5149107526768645;6.573475401781711;82.53300662006848;2.970244267288293;0.0027623054566900678;0.44213944182052767;[CYFIP1, SERPINE1, MYB, AKT1, HOXA5, MEF2A, MEF2C, SPINT1, MAP1B, AGTR1, HOXB4, GATA3, EPB41L5, PRDM16, SFN, NCKAP1L, LYN, FZD1, JUN, JAG1, FN1, COL1A1, EZH2, TGFB1I1, TIMP2, ANXA1, FOS, SIRT1, PAX2, ENG, PTGS2, FRZB, FLNA, CCL19, IL12RB1, TMEM64, PF4, PLXND1, FMR1, TNF, CTGF, CDH5, ATP11C, OLFM4, ADCYAP1, TACSTD2, SOCS2, NFKB1, CXCL12, BCL6, PLXNB2, CYR61, DUSP10, ADAMTS20, CX3CR1, NLGN1, SMARCD3, LRP2, RAB21, FYN, CTHRC1, IRX3, KLF5, CPNE5, RPS6KA1, TNFSF11, EPHB2, FLT3LG, RUNX2, BTC, SFRP4, POR, SFRP2, BTK, EPHA3, TWIST1, INPP5D, CCR1, MSR1, EGR3, TNFSF14, LIF, VNN1, CD24, ROBO2, NRP1, CD36, CD34, CCR2, SYK, NME1, CEACAM1, IL1B, KIT, TLR2, CXCR4, PAK1, PDPN, CTNNA1, CDX2, LILRB2, FKBP1B, IL17A, SCARB2, CD86, CD83, CD80, MPL, IHH, HOXA11, LOXL2, ARHGDIA, IL6R, LTBP3, NLRP3, ECT2, TGFB2, TGFB1, SYT2, VDR, INHBA, IL6, BMP2, LIN28A, FES, TCF4, DOCK5, CXCL9, HMGB2, TMEM100, MYOCD, AXIN2, DNM2, GREM1, ZAP70, IFNG, LTA, PDE5A, SHANK3, LTF, CNR1, MAPK14, CD4, ACIN1]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, IHH, BRCA2, ROPN1L, FBXO5, HOXA5, RUNX2, EREG, BTK, CFTR, GATA3, CCNB1, CCL19, FZD5, CCL21, NR4A2, SLC26A8, PLP1, SLC26A3]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, SPI1, EHMT2, SLA2, SPIB, AKT1, MEF2A, MEF2C, ATF3, GATA3, JUN, JAG1, JUP, NR2F2, PKIG, EZH2, HOXC10, FOS, SIRT1, MMP12, MED23, CKS2, PTAFR, STAT4, ZNF467, USP9Y, ATAD2, PSMC6, PSMC2, PKN1, CCNT2, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, ZNF423, NFKB1, CXCL10, CIITA, FASLG, HHEX, PPP1R12A, PEG3, LRP2, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, SMARCAL1, CCNH, UXT, TNFSF11, SFRP4, SFRP2, IFI27, TGFA, PCBP3, ZNF700, EGR1, EGR2, EGR3, ID1, CD28, ECM1, CD40, SUV39H1, BRCA1, PCSK6, BMI1, CD3D, CD36, RGMA, IL1B, KIT, YAP1, SATB2, IL17A, IHH, NR3C2, LOXL2, CCNE1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, HMGB2, ARHGEF10L, MYOCD, GREM1, ELF3, FBP1, CREB5, TAF9, AURKB, MAPK14, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, HMOX1, ELANE, NKX2-3, FZD1, NFE2, FZD5, PLK1, FZD8, SNAI2, CDKN1A, ZNF367, HAVCR2, BRD2, PAWR, PAX5, PAX2, AES, ENG, ASCL2, EPCAM, NR1H2, GTF2H1, ELP4, PF4, PLXND1, TNF, DACH1, MEN1, TLE4, NACC2, WFS1, HOPX, COPS5, BCL6, MAFF, CYR61, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, RBBP8, IRX3, KLF4, KLF1, KLF8, KLF5, DNAJA3, PPIL4, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, PFN1, BEX1, TWIST1, NHLH2, BCL11B, BCL11A, LIF, TOP2A, AHCTF1, PRL, XPO1, TLR4, TLR2, PURA, CDX2, LILRB1, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, JMY, CREBZF, KDM5D, SLC40A1, TMEM100, CKAP2, DCN, TGFBR3, IFNG, CAMK2D, DLL1, HSPD1, SNCA, LUM, MEIS2, MEIS1, RBMX]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[RUVBL2, TLE4, AXIN2, AES, GREM1, SFRP4, SFRP2, PFDN5, FOXO1, FRZB, CTHRC1, FZD1, EGR1, CAV1, TMEM64, MAPK14, BMP2, SNAI2]
GO:0014807;regulation of somitogenesis;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;45.909253739235254;7.57984905034425;0.0015365414070062774;0.710754145523778;[CDX2, DLL1]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, MEF2C, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, PF4, TNF, CLU, CLEC5A, F2R, ADCYAP1, MSH2, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, CDK1, MYD88, LRRK2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, CX3CR1, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, BRCA1, CTSH, CCR7, CCR5, FCER1G, HCK, RNF144B, CEACAM6, IL1B, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, CTNNA1, LILRB1, CD40LG, GRINA, MAD2L1, IHH, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, GREM1, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, AURKB, HSPD1, SNCA, TEK]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, DUSP10, TIMP3, CSK, EMILIN1, EPHB2, LYN, DUSP1, LIF, KLF4, DUSP6, NLRP12, TLR4, ATF3]
GO:0045880;positive regulation of smoothened signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;187.6437959822434;6.343086423195323;0.006280268983073171;0.6753050999230941;[PRRX1, IHH, POR, CTNNA1]
GO:0048596;embryonic camera-type eye morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;49.04309196241917;7.292166977892469;0.0016414281520649497;0.7238411236270654;[FZD5, IHH]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, TNF, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, P2RX1, MNDA, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, VAV1, IL1B, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, LTBR]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0032331;negative regulation of chondrocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.567899630675686;230.26794502196225;6.781341354126479;0.007706860892188918;0.6977174774718518;[GREM1, EFEMP1, SNAI2, ADAMTS12]
GO:0048074;negative regulation of eye pigmentation;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.418943172295634;9.777073627680469;0.0011519710529389496;0.7902410118609202;[IHH]
